Log in or Sign up for Free to view tailored content for your specialty!
Diabetes Education News
Q&A: What nutrition security can mean for people with diabetes
Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Isabel C. Betancourt, MS, RDN, CDCES, about nutrition insecurity and how a model designed to combat its effects on people with HIV can improve the lives of people with diabetes.
Tandem updates recall of mobile app causing rapid battery depletion of insulin pumps
Tandem Diabetes Care emailed notices to users of version 2.7.1 of the Apple iOS t:connect mobile app warning of possible rapid battery depletion of their insulin pump, according to an FDA press release.
Log in or Sign up for Free to view tailored content for your specialty!
Adults with type 2 diabetes improve HbA1c, medication use with pharmacist referral
Adults with type 2 diabetes who are referred to a clinical pharmacist are more likely to meet their HbA1c goal and receive appropriate medication management of comorbidities than people receiving usual care, according to a presenter.
Education, electronic alerts help cut insulin pen waste at US hospital
A multifaceted intervention implemented at a U.S. hospital reduced insulin pen waste by 18.3% in inpatient adult areas, according to a presenter at the Association of Diabetes Care and Education Specialists annual meeting.
SGLT2 inhibitors greatly underprescribed in patients who qualify for them
In an analysis of more than 3 million U.S. adults, most patients with a class 1a recommendation for SGLT2 inhibitors were not prescribed them, researchers reported in the Journal of the American College of Cardiology.
GLP-1 use tied to lower risk for hyperkalemia than DPP-IV therapy in type 2 diabetes
Adults with type 2 diabetes using a GLP-1 receptor agonist are less likely to develop hyperkalemia than those using a DPP-IV inhibitor, according to a study published in JAMA Internal Medicine.
Tirzepatide linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s
Adults with type 2 diabetes have lower risks for death and major adverse cardiovascular and kidney events if they use tirzepatide compared with GLP-1 receptor agonists, according to observational data published in JAMA Network Open.
Adults maintain drops in body weight, HbA1c at 1 year after duodenal mucosal resurfacing
Adults with obesity and type 2 diabetes had reductions in body weight and HbA1c 1 year after undergoing an endoscopic procedure that resurfaces the duodenum lining, according to top-line results from a real-world registry study.
Most young people with type 1 diabetes meet HbA1c goal with CGM, remote patient monitoring
Young people with type 1 diabetes enrolled in a digital health program with early initiation of continuous glucose monitoring plus remote patient monitoring had better glycemic outcomes than historical controls, according to study data.
FDA approves next-generation CGM with two-step insertion process
FDA approved Medtronic’s next-generation continuous glucose monitor for people with diabetes, according to an industry press release.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read